27 Jun 2019 - Global Ursodeoxycholic
Acid Market is anticipated to
grow at a CAGR of 7% in the forecast period owing to the developments occurring
worldwide and changing demand from patients. Ursodeoxycholic acid is a steroid
bile acid used for treating liver disorder. It naturally occurs in form of bile
acid and is used to liquefy gallstones, which are rich in cholesterol. It also
helps in improving the bile flow in primary biliary cirrhosis.
Ursodeoxycholic
acid dissolves the cholesterol rich gallstones that accumulate due to
cholesterol deposit. The acid helps prevent gallstone formation in patients’
body. Hence, people suffering from this disorder are driving the
ursodeoxycholic acid market. Ursodeoxycholic acid also cures primary biliary
cirrhosis by treating the symptoms. It slows down the spreading of the liver
disorder and the bile duct.
Ursodeoxycholic
acid also treats liver related symptom of cystic fibrosis, which is mostly
present in children of 6-18 years of age. However, few symptoms may hamper the
growth of ursodeoxycholic acid market. These symptoms comprise headache,
diarrhea, hair loss, indigestion, vomiting or nausea, backache, unusual
bleeding or bruising, cloudy and bloody urine, fever and cough, tarry or black
stools, painful and/or frequent urination, swelling of lips, eyelids, tongue
and face.
The
market is categorized on the basis of product type, applications, and
geography. On the basis of product type, market is divided into synthetic
ursodeoxycholic acid and extraction ursodeoxycholic acid. Based on applications,
market is divided into pharmacy and health products.
Geographically,
market is segmented as North America, Europe, Asia Pacific, and RoW (Rest of
the World). Asia Pacific is expected to hold the largest share of
ursodeoxycholic acid market owing to the rise in liver diseases and rising
elderly population in the region.
The
key players in ursodeoxycholic acid market include ICE, Mitsubishi Tanabe
Pharma, Arcelor Chemicals, Daewoong Chemical, Erregierre, Dipharma Francis,
PharmaZell GmbH, Suzhou Tianlu, Grindeks, Abil Chempharma, Biotavia Labs, and
Zhangshanbelling.
Market Segment:
Key Products
•
Cholic Acid-based
•
Chenodeoxycholic Acid-based
Key Regions
•
North America
•
Europe
•
Asia Pacific
•
Middle East and Africa
•
South America
Key Vendors
•
Daewoong Bio
•
Dipharma
•
ICE
•
PharmaZell
•
Suzhou Tianlu
•
Zhongshan Belling
•
request free sample to get a complete list of companies
Comments
Post a Comment